Predictors of mortality within 6 weeks after treatment of gastric variceal bleeding in cirrhotic patients

Medicine (United States)

Volumn 93, Issue 29, 2014, Pages e321-

  Teng, Wei ^a   Chen, Wei Ting ^a   Ho, Yu Pin ^a   Jeng, Wen Juei ^a   Huang, Chien Hao ^a   Chen, Yi Cheng ^a   Lin, Shi Ming ^a   Chiu, Cheng Tang ^a   Lin, Chun Yen ^a   Sheen, I Shyan ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ENBUCRILATE; PROTON PUMP INHIBITOR; SOMATOSTATIN; TERLIPRESSIN; HEMOSTATIC AGENT;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; CHILD TURCOTTE PUGH SCORE; END STAGE LIVER DISEASE; ENDOSCOPIC THERAPY; FEMALE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; STOMACH VARICES BLEEDING; TREATMENT OUTCOME; COMPLICATION; ESOPHAGUS VARICES; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; KIDNEY FAILURE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENT DISEASE; SEVERITY OF ILLNESS INDEX;

ACUTE-ON-CHRONIC LIVER FAILURE; ENBUCRILATE; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTATICS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84920769939     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000321     Document Type: Article

References (48)

1. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922-938.
2. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823-832.
3. Jairath V, Rehal S, Logan R, et al. Acute variceal haemorrhage in the United Kingdom: Patient characteristics, management and outcomes in a nationwide audit. Dig Liver Dis. 2014;46:419-426.
4. Kim T, Shijo H, Kokawa H, et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology. 1997;25:307-312.
5. Chang YJ, Park JJ, Joo MK, et al. Long-term outcomes of prophylactic endoscopic histoacryl injection for gastric varices with a high risk of bleeding. Digest Dis Sci. 2010;55:2391-2397.
6. Prachayakul V, Aswakul P, Chantarojanasiri T, et al. Factors influencing clinical outcomes of Histoacryl(R) glue injection-treated gastric variceal hemorrhage. World J Gastroenterol. 2013;19:2379-2387.
7. Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992;16:1343-1349.
8. Hou MC, Lin HC, Lee HS, et al. A randomized trial of endoscopic cyanoacrylate injection for acute gastric variceal bleeding: 0.5 mL versus 10 mL. Gastrointest Endosc. 2009;70:668-675.
9. Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117:626-631.
10. Moitinho E, Planas R, Banares R, et al. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol. 2001;35:712-718.
11. D'Amico G, De Franchis R, Cooperative Study G. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599-612.
12. Abraldes JG, Villanueva C, Banares R, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008;48:229-236.
13. Augustin S, Muntaner L, Altamirano JT, et al. Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis. Clin Gastroenterol Hepatol. 2009;7:1347-1354.
14. Augustin S, Altamirano J, Gonzalez A, et al. Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding. Am J Gastroenterol. 2011;106:1787-1795.
15. Tan PC, Hou MC, Lin HC, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology. 2006;43:690-697.
16. de Franchis R, Baveno VF. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762-768.
17. Hashizume M, Kitano S, Yamaga H, et al. Endoscopic classification of gastric varices. Gastrointest Endosc. 1990;36:276-280.
18. Sarin SK, Kumar A, Angus PW, et al. Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int. 2011;5:607-624.
19. Terg R, Gadano A, Cartier M, et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver Int. 2009;29:415-419.
20. Tsien CD, Rabie R, Wong F. Acute kidney injury in decompensated cirrhosis. Gut. 2013;62:131-137.
21. Bone RC. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest J. 1992;101:1644.
22. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426-1437.
23. Rerknimitr R, Chanyaswad J, Kongkam P, et al. Risk of bacteremia in bleeding and nonbleeding gastric varices after endoscopic injection of cyanoacrylate. Endoscopy. 2008;40:644-649.
24. Chen WT, Lin CY, Sheen IS, et al. MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World J Gastroenterol. 2011;17:2120-2125.
25. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11-21.
26. Seewald S, Ang TL, Imazu H, et al. A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos). Gastrointest Endosc. 2008;68:447-454.
27. Cheng LF, Wang ZQ, Li CZ, et al. Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate. Clin Gastroenterol Hepatol. 2010;8:760-766.
28. Battaglia G, Morbin T, Patarnello E, et al. Visceral fistula as a complication of endoscopic treatment of esophageal and gastric varices using isobutyl-2-cyanoacrylate: report of two cases. Gastrointest Endosc. 2000;52:267-270.
29. Greenwald BD, Caldwell SH, Hespenheide EE, et al. N-2-butylcyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis. Am J Gastroenterol. 2003;98:1982-1988.
30. Tan YM, Goh KL, Kamarulzaman A, et al. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc. 2002;55:276-278.
31. Chen YY, Shen TC, Soon MS, et al. Life-threatening pericarditis after N-butyl-2-cyanoacrylate injection for esophageal variceal bleeding: case report. Gastrointest Endosc. 2005;61:487-489.
32. Chalasani N, Kahi C, Francois F, et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology. 2002;35:1282-1284.
33. Bambha K, Kim WR, Pedersen R, et al. Predictors of early rebleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut. 2008;57:814-820.
34. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231.
35. Jalan R, Gines P, Olson JC, et al. Acute-on chronic liver failure. J Hepatol. 2012;57:1336-1348.
36. Wlodzimirow K, Abu-Hanna A, Chamuleau RA. Acute-on-chronic liver failure - its definition remains unclear. J Hepatol. 2013;59:190-191.
37. Altamirano J, Fagundes C, Dominguez M, et al. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. Clin Gastroenterol Hepatol. 2012;10:65-71.
38. Cazzaniga M, Dionigi E, Gobbo G, et al. The systemic inflammatory response syndrome in cirrhotic patients: relationship with their inhospital outcome. J Hepatol. 2009;51:475-482.
39. Terra C, Guevara M, Torre A, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology. 2005;129:1944-1953.
40. Simmons EM, Himmelfarb J, Sezer MT, et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int. 2004;65:1357-1365.
41. Thabut D, Massard J, Gangloff A, et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology. 2007;46:1872-1882.
42. Avgerinos A, Armonis A, Stefanidis G, et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology. 2004;39:1623-1630.
43. Tripathi D, Therapondos G, Jackson E, et al. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut. 2002;51:270-274.
44. Toyonaga A, Iwao T, Sumino M, et al. Portal pressure after prophylactic sclerotherapy in patients with high-risk varices. J Hepatol. 1994;21:515-520.
45. Garcia-Pagan JC, Barrufet M, Cardenas A, et al. Management of gastric varices. Clin Gastroenterol Hepatol. 2014;12:919-928.
46. Girotra M, Raghavapuram S, Abraham RR, et al. Management of gastric variceal bleeding: role of endoscopy and endoscopic ultrasound. World J Hepatol. 2014;6:130-136.
47. Naeshiro N, Aikata H, Kakizawa H, et al. Long-term outcome of patients with gastric varices treated by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 2014;29:1035-1042.
48. Han ML, Chen CC, Kuo SH, et al. Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis. J Gastroenterol Hepatol. 2014;29:344-351.